LFSC ETF top 10 holdings are 56.0% of the fund as of Aug 6, 2026
LFSC ETF top 10 holdings are 56.0% of the fund as of Aug 6, 2026
$47.44
AUM$128M
TER0.54%
Holdings40
See how much of LFSC you already own
LFSC ETF top 10 holdings are 56.0% of the fund as of Aug 6, 2026
$47.44
F/m Emerald Life Sciences Innovation ETF
AUM$128M
TER0.54%
Holdings40
See how much of LFSC you already own
LFSC holds 56.0% of its assets in its 10 largest positions as of Aug 6, 2026. LFSC is F/m Emerald Life Sciences Innovation ETF.
LFSC ETF Top Holdings
LFSC holdings top 10 positions. The top 10 holdings account for 56.0% of the fund, led by Travere Therapeutics Inc at 8.6%, Spyre Therapeutics Inc at 7.7%, Cogent Biosciences Inc at 7.7%.
LFSC portfolio concentration is relatively high, with the top 10 representing 56.0% of total assets. The largest sector exposure is Health Care at 86.3%.
LFSC sectors provide a detailed breakdown. LFSC overlap shows how holdings compare to other funds in your portfolio.








